Loading
Life sciences · Journal article
Global Health Care · November 8, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Lactate accumulation in the tumor microenvironment is an important factor inducing CD8⁺ T cell exhaustion and immunotherapy resistance, but whether reprogramming lactate metabolism can reverse CD8⁺ T cell exhaustion remains unclear. This study aims to explore the effects of targeted lactate metabolism on CD8⁺ T cell function and anti-tumor immunotherapy. Single-cell RNA sequencing, metabolomics, flow cytometry, and immunohistochemistry were used to analyze the lactate metabolism characteristics and exhaustion phenotypes of tumor-infiltrated CD8⁺ T cells; Genetics or pharmacological methods were used to regulate lactate dehydrogenase A (LDHA) and the lactate transporter MCT1/4, and to evaluate anti-tumor effects and synergistic effects with anti-PD-1 therapy in tumor-bearing mouse models of B16-OVA and MC38. Lactate uptake in tumor-infiltrating CD8⁺ T cells increases, with significant upregulation of MCT1/4 and LDHA, accompanied by decreased mitochondrial membrane potential, impaired oxidative phosphorylation, and increased expression of depletion markers such as PD-1, TIM-3, LAG-3, and TOX/NR4A. Inhibiting LDHA or blocking MCT1/4 lowers intracellular lactate levels, restores mitochondrial function and oxidative phosphorylation, enhances secretion of IFN-γ, TNF-α, and granzyme B, and downregulates depletion-related transcriptional programs. In tumor-bearing mice, reprogramming of lactate metabolism significantly inhibits tumor growth, increases the proportion of tumor-infiltrating CD8⁺ T cells and effector memory phenotypes, and produces synergistic effects with anti-PD-1 therapy. Mechanistically, lactate regulates the expression of exhaustion-related genes through histone lactation modification, while metabolic intervention can reverse this epigenetic program. Targeted lactate metabolism reprogramming can effectively reverse CD8⁺ T cell exhaustion, enhance the efficacy of tumor immunotherapy, and provide new potential targets for solid tumor immunotherapy.